ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Non-Opioid Patch Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-39K14285
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Non Opioid Patch Market Research Report 2023
BUY CHAPTERS

Global Non-Opioid Patch Market Research Report 2025

Code: QYRE-Auto-39K14285
Report
May 2025
Pages:82
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Viatris
Johnson and Johnson
Teva Pharmaceutical Industries Ltd
Sorrento Therapeutics Inc
Grunenthal
NEXGEL Advanced Hydrogel Solutions
Hisamitsu Pharmaceutical Co Inc
Endo International Plc.
Amneal Pharmaceuticals LLC
Purdue Pharma L.P

Non-Opioid Patch Market

The global market for Non-Opioid Patch was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
A Non-Opioid Patch is a transdermal patch used for pain management. Unlike opioid-based patches, non-opioid patches deliver medications that are not opioids, such as nonsteroidal anti-inflammatory drugs (NSAIDs) or lidocaine, to provide pain relief without the risk of opioid addiction or dependence.
A Non-Opioid Patch is a medical patch or transdermal delivery system that releases medications for pain relief without containing opioids. These patches are used to manage various types of pain, such as chronic pain, post-surgery pain, or pain associated with certain medical conditions.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Non-Opioid Patch, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Opioid Patch.
The Non-Opioid Patch market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Non-Opioid Patch market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-Opioid Patch manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Non-Opioid Patch Market Report

Report Metric Details
Report Name Non-Opioid Patch Market
Segment by Type
  • Prescription Medicines
  • OTC Medicines
Segment by Application
  • Hospital Pharmacies
  • Drug Stores
  • Online Pharmacies
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company NEXGEL Advanced Hydrogel Solutions, Viatris Inc., Johnson and Johnson, Teva Pharmaceutical Industries Ltd, Sorrento Therapeutics Inc., Hisamitsu Pharmaceutical Co.,Inc., Endo International plc., Purdue Pharma L.P., Amneal Pharmaceuticals LLC, Grunenthal
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Non-Opioid Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Non-Opioid Patch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Non-Opioid Patch Market report?

Ans: The main players in the Non-Opioid Patch Market are NEXGEL Advanced Hydrogel Solutions, Viatris Inc., Johnson and Johnson, Teva Pharmaceutical Industries Ltd, Sorrento Therapeutics Inc., Hisamitsu Pharmaceutical Co.,Inc., Endo International plc., Purdue Pharma L.P., Amneal Pharmaceuticals LLC, Grunenthal

What are the Application segmentation covered in the Non-Opioid Patch Market report?

Ans: The Applications covered in the Non-Opioid Patch Market report are Hospital Pharmacies, Drug Stores, Online Pharmacies

What are the Type segmentation covered in the Non-Opioid Patch Market report?

Ans: The Types covered in the Non-Opioid Patch Market report are Prescription Medicines, OTC Medicines

1 Non-Opioid Patch Market Overview
1.1 Product Definition
1.2 Non-Opioid Patch by Type
1.2.1 Global Non-Opioid Patch Market Value Comparison by Type (2024 VS 2031)
1.2.2 Prescription Medicines
1.2.3 OTC Medicines
1.3 Non-Opioid Patch by Application
1.3.1 Global Non-Opioid Patch Market Value by Application (2024 VS 2031)
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.3.4 Online Pharmacies
1.4 Global Non-Opioid Patch Market Size Estimates and Forecasts
1.4.1 Global Non-Opioid Patch Revenue 2020-2031
1.4.2 Global Non-Opioid Patch Sales 2020-2031
1.4.3 Global Non-Opioid Patch Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Non-Opioid Patch Market Competition by Manufacturers
2.1 Global Non-Opioid Patch Sales Market Share by Manufacturers (2020-2025)
2.2 Global Non-Opioid Patch Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Non-Opioid Patch Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Non-Opioid Patch, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Non-Opioid Patch, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Non-Opioid Patch, Product Type & Application
2.7 Global Key Manufacturers of Non-Opioid Patch, Date of Enter into This Industry
2.8 Global Non-Opioid Patch Market Competitive Situation and Trends
2.8.1 Global Non-Opioid Patch Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Non-Opioid Patch Players Market Share by Revenue
2.8.3 Global Non-Opioid Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Non-Opioid Patch Market Scenario by Region
3.1 Global Non-Opioid Patch Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Non-Opioid Patch Sales by Region: 2020-2031
3.2.1 Global Non-Opioid Patch Sales by Region: 2020-2025
3.2.2 Global Non-Opioid Patch Sales by Region: 2026-2031
3.3 Global Non-Opioid Patch Revenue by Region: 2020-2031
3.3.1 Global Non-Opioid Patch Revenue by Region: 2020-2025
3.3.2 Global Non-Opioid Patch Revenue by Region: 2026-2031
3.4 North America Non-Opioid Patch Market Facts & Figures by Country
3.4.1 North America Non-Opioid Patch Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Non-Opioid Patch Sales by Country (2020-2031)
3.4.3 North America Non-Opioid Patch Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Non-Opioid Patch Market Facts & Figures by Country
3.5.1 Europe Non-Opioid Patch Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Non-Opioid Patch Sales by Country (2020-2031)
3.5.3 Europe Non-Opioid Patch Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-Opioid Patch Market Facts & Figures by Region
3.6.1 Asia Pacific Non-Opioid Patch Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Non-Opioid Patch Sales by Region (2020-2031)
3.6.3 Asia Pacific Non-Opioid Patch Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Non-Opioid Patch Market Facts & Figures by Country
3.7.1 Latin America Non-Opioid Patch Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Non-Opioid Patch Sales by Country (2020-2031)
3.7.3 Latin America Non-Opioid Patch Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Non-Opioid Patch Market Facts & Figures by Country
3.8.1 Middle East and Africa Non-Opioid Patch Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Non-Opioid Patch Sales by Country (2020-2031)
3.8.3 Middle East and Africa Non-Opioid Patch Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Non-Opioid Patch Sales by Type (2020-2031)
4.1.1 Global Non-Opioid Patch Sales by Type (2020-2025)
4.1.2 Global Non-Opioid Patch Sales by Type (2026-2031)
4.1.3 Global Non-Opioid Patch Sales Market Share by Type (2020-2031)
4.2 Global Non-Opioid Patch Revenue by Type (2020-2031)
4.2.1 Global Non-Opioid Patch Revenue by Type (2020-2025)
4.2.2 Global Non-Opioid Patch Revenue by Type (2026-2031)
4.2.3 Global Non-Opioid Patch Revenue Market Share by Type (2020-2031)
4.3 Global Non-Opioid Patch Price by Type (2020-2031)
5 Segment by Application
5.1 Global Non-Opioid Patch Sales by Application (2020-2031)
5.1.1 Global Non-Opioid Patch Sales by Application (2020-2025)
5.1.2 Global Non-Opioid Patch Sales by Application (2026-2031)
5.1.3 Global Non-Opioid Patch Sales Market Share by Application (2020-2031)
5.2 Global Non-Opioid Patch Revenue by Application (2020-2031)
5.2.1 Global Non-Opioid Patch Revenue by Application (2020-2025)
5.2.2 Global Non-Opioid Patch Revenue by Application (2026-2031)
5.2.3 Global Non-Opioid Patch Revenue Market Share by Application (2020-2031)
5.3 Global Non-Opioid Patch Price by Application (2020-2031)
6 Key Companies Profiled
6.1 NEXGEL Advanced Hydrogel Solutions
6.1.1 NEXGEL Advanced Hydrogel Solutions Company Information
6.1.2 NEXGEL Advanced Hydrogel Solutions Description and Business Overview
6.1.3 NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Sales, Revenue and Gross Margin (2020-2025)
6.1.4 NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Product Portfolio
6.1.5 NEXGEL Advanced Hydrogel Solutions Recent Developments/Updates
6.2 Viatris Inc.
6.2.1 Viatris Inc. Company Information
6.2.2 Viatris Inc. Description and Business Overview
6.2.3 Viatris Inc. Non-Opioid Patch Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Viatris Inc. Non-Opioid Patch Product Portfolio
6.2.5 Viatris Inc. Recent Developments/Updates
6.3 Johnson and Johnson
6.3.1 Johnson and Johnson Company Information
6.3.2 Johnson and Johnson Description and Business Overview
6.3.3 Johnson and Johnson Non-Opioid Patch Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Johnson and Johnson Non-Opioid Patch Product Portfolio
6.3.5 Johnson and Johnson Recent Developments/Updates
6.4 Teva Pharmaceutical Industries Ltd
6.4.1 Teva Pharmaceutical Industries Ltd Company Information
6.4.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
6.4.3 Teva Pharmaceutical Industries Ltd Non-Opioid Patch Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Teva Pharmaceutical Industries Ltd Non-Opioid Patch Product Portfolio
6.4.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
6.5 Sorrento Therapeutics Inc.
6.5.1 Sorrento Therapeutics Inc. Company Information
6.5.2 Sorrento Therapeutics Inc. Description and Business Overview
6.5.3 Sorrento Therapeutics Inc. Non-Opioid Patch Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Sorrento Therapeutics Inc. Non-Opioid Patch Product Portfolio
6.5.5 Sorrento Therapeutics Inc. Recent Developments/Updates
6.6 Hisamitsu Pharmaceutical Co.,Inc.
6.6.1 Hisamitsu Pharmaceutical Co.,Inc. Company Information
6.6.2 Hisamitsu Pharmaceutical Co.,Inc. Description and Business Overview
6.6.3 Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Product Portfolio
6.6.5 Hisamitsu Pharmaceutical Co.,Inc. Recent Developments/Updates
6.7 Endo International plc.
6.7.1 Endo International plc. Company Information
6.7.2 Endo International plc. Description and Business Overview
6.7.3 Endo International plc. Non-Opioid Patch Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Endo International plc. Non-Opioid Patch Product Portfolio
6.7.5 Endo International plc. Recent Developments/Updates
6.8 Purdue Pharma L.P.
6.8.1 Purdue Pharma L.P. Company Information
6.8.2 Purdue Pharma L.P. Description and Business Overview
6.8.3 Purdue Pharma L.P. Non-Opioid Patch Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Purdue Pharma L.P. Non-Opioid Patch Product Portfolio
6.8.5 Purdue Pharma L.P. Recent Developments/Updates
6.9 Amneal Pharmaceuticals LLC
6.9.1 Amneal Pharmaceuticals LLC Company Information
6.9.2 Amneal Pharmaceuticals LLC Description and Business Overview
6.9.3 Amneal Pharmaceuticals LLC Non-Opioid Patch Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Amneal Pharmaceuticals LLC Non-Opioid Patch Product Portfolio
6.9.5 Amneal Pharmaceuticals LLC Recent Developments/Updates
6.10 Grunenthal
6.10.1 Grunenthal Company Information
6.10.2 Grunenthal Description and Business Overview
6.10.3 Grunenthal Non-Opioid Patch Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Grunenthal Non-Opioid Patch Product Portfolio
6.10.5 Grunenthal Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Non-Opioid Patch Industry Chain Analysis
7.2 Non-Opioid Patch Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-Opioid Patch Production Mode & Process Analysis
7.4 Non-Opioid Patch Sales and Marketing
7.4.1 Non-Opioid Patch Sales Channels
7.4.2 Non-Opioid Patch Distributors
7.5 Non-Opioid Patch Customer Analysis
8 Non-Opioid Patch Market Dynamics
8.1 Non-Opioid Patch Industry Trends
8.2 Non-Opioid Patch Market Drivers
8.3 Non-Opioid Patch Market Challenges
8.4 Non-Opioid Patch Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Viatris
Johnson and Johnson
Teva Pharmaceutical Industries Ltd
Sorrento Therapeutics Inc
Grunenthal
NEXGEL Advanced Hydrogel Solutions
Hisamitsu Pharmaceutical Co Inc
Endo International Plc.
Amneal Pharmaceuticals LLC
Purdue Pharma L.P
List of Tables
 Table 1. Global Non-Opioid Patch Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Non-Opioid Patch Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Non-Opioid Patch Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Non-Opioid Patch Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Non-Opioid Patch Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Non-Opioid Patch Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Non-Opioid Patch Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Non-Opioid Patch Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Non-Opioid Patch, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Non-Opioid Patch, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Non-Opioid Patch, Product Type & Application
 Table 12. Global Key Manufacturers of Non-Opioid Patch, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Non-Opioid Patch by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Opioid Patch as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Non-Opioid Patch Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Non-Opioid Patch Sales by Region (2020-2025) & (K Units)
 Table 18. Global Non-Opioid Patch Sales Market Share by Region (2020-2025)
 Table 19. Global Non-Opioid Patch Sales by Region (2026-2031) & (K Units)
 Table 20. Global Non-Opioid Patch Sales Market Share by Region (2026-2031)
 Table 21. Global Non-Opioid Patch Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Non-Opioid Patch Revenue Market Share by Region (2020-2025)
 Table 23. Global Non-Opioid Patch Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Non-Opioid Patch Revenue Market Share by Region (2026-2031)
 Table 25. North America Non-Opioid Patch Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Non-Opioid Patch Sales by Country (2020-2025) & (K Units)
 Table 27. North America Non-Opioid Patch Sales by Country (2026-2031) & (K Units)
 Table 28. North America Non-Opioid Patch Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Non-Opioid Patch Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Non-Opioid Patch Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Non-Opioid Patch Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Non-Opioid Patch Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Non-Opioid Patch Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Non-Opioid Patch Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Non-Opioid Patch Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Non-Opioid Patch Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Non-Opioid Patch Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Non-Opioid Patch Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Non-Opioid Patch Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Non-Opioid Patch Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Non-Opioid Patch Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Non-Opioid Patch Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Non-Opioid Patch Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Non-Opioid Patch Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Non-Opioid Patch Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Non-Opioid Patch Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Non-Opioid Patch Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Non-Opioid Patch Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Non-Opioid Patch Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Non-Opioid Patch Sales (K Units) by Type (2020-2025)
 Table 51. Global Non-Opioid Patch Sales (K Units) by Type (2026-2031)
 Table 52. Global Non-Opioid Patch Sales Market Share by Type (2020-2025)
 Table 53. Global Non-Opioid Patch Sales Market Share by Type (2026-2031)
 Table 54. Global Non-Opioid Patch Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Non-Opioid Patch Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Non-Opioid Patch Revenue Market Share by Type (2020-2025)
 Table 57. Global Non-Opioid Patch Revenue Market Share by Type (2026-2031)
 Table 58. Global Non-Opioid Patch Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Non-Opioid Patch Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Non-Opioid Patch Sales (K Units) by Application (2020-2025)
 Table 61. Global Non-Opioid Patch Sales (K Units) by Application (2026-2031)
 Table 62. Global Non-Opioid Patch Sales Market Share by Application (2020-2025)
 Table 63. Global Non-Opioid Patch Sales Market Share by Application (2026-2031)
 Table 64. Global Non-Opioid Patch Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Non-Opioid Patch Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Non-Opioid Patch Revenue Market Share by Application (2020-2025)
 Table 67. Global Non-Opioid Patch Revenue Market Share by Application (2026-2031)
 Table 68. Global Non-Opioid Patch Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Non-Opioid Patch Price (US$/Unit) by Application (2026-2031)
 Table 70. NEXGEL Advanced Hydrogel Solutions Company Information
 Table 71. NEXGEL Advanced Hydrogel Solutions Description and Business Overview
 Table 72. NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. NEXGEL Advanced Hydrogel Solutions Non-Opioid Patch Product
 Table 74. NEXGEL Advanced Hydrogel Solutions Recent Developments/Updates
 Table 75. Viatris Inc. Company Information
 Table 76. Viatris Inc. Description and Business Overview
 Table 77. Viatris Inc. Non-Opioid Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Viatris Inc. Non-Opioid Patch Product
 Table 79. Viatris Inc. Recent Developments/Updates
 Table 80. Johnson and Johnson Company Information
 Table 81. Johnson and Johnson Description and Business Overview
 Table 82. Johnson and Johnson Non-Opioid Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Johnson and Johnson Non-Opioid Patch Product
 Table 84. Johnson and Johnson Recent Developments/Updates
 Table 85. Teva Pharmaceutical Industries Ltd Company Information
 Table 86. Teva Pharmaceutical Industries Ltd Description and Business Overview
 Table 87. Teva Pharmaceutical Industries Ltd Non-Opioid Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Teva Pharmaceutical Industries Ltd Non-Opioid Patch Product
 Table 89. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
 Table 90. Sorrento Therapeutics Inc. Company Information
 Table 91. Sorrento Therapeutics Inc. Description and Business Overview
 Table 92. Sorrento Therapeutics Inc. Non-Opioid Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Sorrento Therapeutics Inc. Non-Opioid Patch Product
 Table 94. Sorrento Therapeutics Inc. Recent Developments/Updates
 Table 95. Hisamitsu Pharmaceutical Co.,Inc. Company Information
 Table 96. Hisamitsu Pharmaceutical Co.,Inc. Description and Business Overview
 Table 97. Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Hisamitsu Pharmaceutical Co.,Inc. Non-Opioid Patch Product
 Table 99. Hisamitsu Pharmaceutical Co.,Inc. Recent Developments/Updates
 Table 100. Endo International plc. Company Information
 Table 101. Endo International plc. Description and Business Overview
 Table 102. Endo International plc. Non-Opioid Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Endo International plc. Non-Opioid Patch Product
 Table 104. Endo International plc. Recent Developments/Updates
 Table 105. Purdue Pharma L.P. Company Information
 Table 106. Purdue Pharma L.P. Description and Business Overview
 Table 107. Purdue Pharma L.P. Non-Opioid Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Purdue Pharma L.P. Non-Opioid Patch Product
 Table 109. Purdue Pharma L.P. Recent Developments/Updates
 Table 110. Amneal Pharmaceuticals LLC Company Information
 Table 111. Amneal Pharmaceuticals LLC Description and Business Overview
 Table 112. Amneal Pharmaceuticals LLC Non-Opioid Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Amneal Pharmaceuticals LLC Non-Opioid Patch Product
 Table 114. Amneal Pharmaceuticals LLC Recent Developments/Updates
 Table 115. Grunenthal Company Information
 Table 116. Grunenthal Description and Business Overview
 Table 117. Grunenthal Non-Opioid Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Grunenthal Non-Opioid Patch Product
 Table 119. Grunenthal Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Non-Opioid Patch Distributors List
 Table 123. Non-Opioid Patch Customers List
 Table 124. Non-Opioid Patch Market Trends
 Table 125. Non-Opioid Patch Market Drivers
 Table 126. Non-Opioid Patch Market Challenges
 Table 127. Non-Opioid Patch Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Non-Opioid Patch
 Figure 2. Global Non-Opioid Patch Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Non-Opioid Patch Market Share by Type: 2024 & 2031
 Figure 4. Prescription Medicines Product Picture
 Figure 5. OTC Medicines Product Picture
 Figure 6. Global Non-Opioid Patch Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Non-Opioid Patch Market Share by Application: 2024 & 2031
 Figure 8. Hospital Pharmacies
 Figure 9. Drug Stores
 Figure 10. Online Pharmacies
 Figure 11. Global Non-Opioid Patch Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Non-Opioid Patch Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Non-Opioid Patch Sales (2020-2031) & (K Units)
 Figure 14. Global Non-Opioid Patch Average Price (US$/Unit) & (2020-2031)
 Figure 15. Non-Opioid Patch Report Years Considered
 Figure 16. Non-Opioid Patch Sales Share by Manufacturers in 2024
 Figure 17. Global Non-Opioid Patch Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Non-Opioid Patch Players: Market Share by Revenue in Non-Opioid Patch in 2024
 Figure 19. Non-Opioid Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Non-Opioid Patch Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Non-Opioid Patch Sales Market Share by Country (2020-2031)
 Figure 22. North America Non-Opioid Patch Revenue Market Share by Country (2020-2031)
 Figure 23. United States Non-Opioid Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Non-Opioid Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Non-Opioid Patch Sales Market Share by Country (2020-2031)
 Figure 26. Europe Non-Opioid Patch Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Non-Opioid Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Non-Opioid Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Non-Opioid Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Non-Opioid Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Non-Opioid Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Non-Opioid Patch Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Non-Opioid Patch Revenue Market Share by Region (2020-2031)
 Figure 34. China Non-Opioid Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Non-Opioid Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Non-Opioid Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Non-Opioid Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Non-Opioid Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Non-Opioid Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Non-Opioid Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Non-Opioid Patch Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Non-Opioid Patch Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Non-Opioid Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Non-Opioid Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Non-Opioid Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Non-Opioid Patch Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Non-Opioid Patch Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Non-Opioid Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Non-Opioid Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Non-Opioid Patch Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Non-Opioid Patch by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Non-Opioid Patch by Type (2020-2031)
 Figure 53. Global Non-Opioid Patch Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Non-Opioid Patch by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Non-Opioid Patch by Application (2020-2031)
 Figure 56. Global Non-Opioid Patch Price (US$/Unit) by Application (2020-2031)
 Figure 57. Non-Opioid Patch Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Non opioid Pain Patch Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Non opioid Pain Patches Market Research Report 2024
Global Non opioid Analgesic Patch Market Research Report 2024
Transdermal Drug Delivery Patches Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Transdermal Patch for Pain Relief Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Non Opioid Pain Relief Device Market Research Report 2024
Global Pain Relief Patches Market Research Report 2025
Global Topical Pain Relief Patch Market Research Report 2024
Pain Relieving Patches Market
Global Buprenorphine Patches Market Research Report 2024
Global Lidocaine Patch Market Research Report 2024
Global Non Opioid Pain Treatment Market Insights Forecast to 2030
Global Indometacin Patches Market Research Report 2024
Global Medicated Adhesive Patch Market Insights Forecast to 2030
Global Piroxicam Patch Market Research Report 2024
Pain Management Product Market
OTC Transdermal Analgesic Patches Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Loxoprofen Sodium Gel Patch Market Research Report 2024
Global Flurbiprofen Gel Patch Market Research Report 2024
Transdermal Medical Patch Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions